相关实验视频
Updated: Jun 15, 2025
11:53
Cecal Ligation Puncture Procedure
Published on: May 7, 2011
54.8K
中度IV液体复苏与败血症死亡率降低有关
Keith A Corl1, Mitchell M Levy2, Andre L Holder3,4
1Division of Pulmonary Critical Care, Kaiser Permanente, Modesto, CA.
Critical care medicine
|August 23, 2024
概括
医生实践的变化显著影响了败血症死亡率. 在败血症患者中,静脉注射 (IV) 液体复苏的适度方法与死亡率的降低有关,需要进一步调查.
科学领域:
- 关键护理医学 关键护理医学
- 临床实践变化 临床实践变化
- 败血症管理管理
背景情况:
- 对于败血症患者,静脉注射 (IV) 液体的使用存在显著差异.
- 目前的证据提供了限制性和自由流体策略之间的平衡,但缺乏关于更广泛的复苏实践的数据.
研究的目的:
- 调查各种液体复苏实践与败血症死亡率之间的关联.
- 确定导致败血症管理实践变化的主要因素.
主要方法:
- 首席医疗保健数据库的回顾性分析.
- 包括190,682名患有败血症和败血症休克的患者在612家美国医院 (2016-2019).
- 检查医院第一天给出的IV液体体积及其与死亡率的相关性.
主要成果:
- 与预测的狭窄范围 (3.6-4.5 L) 相比,观察到平均IV液体给药量 (95%范围,1.7-7.4 L) 的广泛变化.
- 接受中等量IV液体 (4.0升) 的患者在风险调整后的死亡率下降了2.5%,而不是非常低或非常高的体积组 (p < 0.01).
- 医院内医生之间的差异,而不是医院间的差异,是观察到的实践差异的主要驱动因素.
结论:
- 个体医生实践模式是感染败血症IV液体复苏过度变化的主要来源.
- 适度的IV液体复苏策略表明与降低败血症死亡率的关联.
- 建议在未来进行随机对照试验,以验证这些发现.
相关概念视频
01:29Acute Respiratory Failure-V
126
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
126
01:28Pneumonia IV: Management
312
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
312
01:22Methods of reducing fever
649
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
649
01:30Pneumonia V: Nursing management and Prevention
1.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.9K
01:28Pleural Effusion II: Symptoms and Management
160
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
160